XML 1023 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 25, 2021
Dec. 26, 2020
Dec. 28, 2019
OPERATING ACTIVITIES      
Net income $ 381,524 $ 192,106 $ 227,703
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization of operating property and intangible assets 49,609 45,855 44,468
Non-cash interest charges 447 334 253
Provisions for losses on trade and other accounts receivable 5,722 9,415 9,831
Gains on sales/disposals of operating property (1,830) (2,576) (1,016)
Impairment of intangible and other assets 0 2,582 0
Deferred income taxes, net (3,790) 1,130 4,767
Stock-based compensation 27,537 4,639 4,236
Changes in operating assets and liabilities:      
(Increase) decrease in trade and other accounts receivable (362,234) (285,169) 81,415
Decrease (increase) in other assets 4,444 (4,719) (11,395)
Increase (decrease) in accounts payable 224,125 108,090 (42,138)
Increase (decrease) in other liabilities 43,422 28,496 (17,786)
(Decrease) increase in insurance claims (92,236) 110,534 7,502
NET CASH PROVIDED BY OPERATING ACTIVITIES 276,740 210,717 307,840
INVESTING ACTIVITIES      
Net change in other short-term investments 0 131 (131)
Sales and maturities of investments 31,938 22,632 62,922
Purchases of investments (84,992) (25,550) (65,922)
Purchases of operating property (23,261) (30,626) (19,416)
Proceeds from sales of operating property 2,971 7,760 3,991
Consideration paid for acquisition 0 (2,766) 0
NET CASH USED BY INVESTING ACTIVITIES (73,344) (28,419) (18,556)
FINANCING ACTIVITIES      
Increase (decrease) in cash overdraft 41,730 20,870 (1,461)
Dividends paid (111,961) (109,504) (27,891)
Payment for debt issue costs 0 (1,132) 0
Proceeds from exercises of stock options 160 725 1,056
Taxes paid in lieu of shares issued related to stock-based compensation plans (2,342) (3,326) (8,456)
Purchases of common stock (122,722) (115,962) (88,578)
Principal payments on finance lease obligations (37,644) (43,703) (44,635)
Purchase of noncontrolling interest 0 0 (600)
Payment of deferred consideration (168) 0 0
NET CASH USED BY FINANCING ACTIVITIES (232,947) (252,032) (170,565)
Effect of exchange rate changes on cash and cash equivalents (232) (427) 1,060
(Decrease) increase in cash, cash equivalents and and restricted cash (29,783) (70,161) 119,779
Cash, cash equivalents and restricted cash at beginning of period 249,354 319,515 199,736
Cash, cash equivalents and restricted cash at end of period $ 219,571 $ 249,354 $ 319,515